CS: Investigation, Methodology, Writing original draft
AOD-9604, sometimes called the fat-burning peptide, showed limited promise in animal studies but has failed to demonstrate consistent results in people, leading the FDA to explicitly state it is not an approved treatment (FDA on unapproved drugs)
Metabolic Pharmaceuticals Phase IIb obesity program completed but did not advance to registration
A 2016 study involving hospitalized people found that the participants with high B12 levels needed longer hospital stays and had a higher chance of dying
The Vitamin B12 Injection form allows for effective administration, particularly for individuals who cannot absorb vitamin B12 effectively through oral supplementation due to gastrointestinal issues
The same holds true for people who suspect they have B12 deficiency, and already start to supplement with oral B12